NEUROSCIENCE, NEUROPHARMACOLOGY AND EXERCISE SCIENCE
Dr Jacob Thorstensen,
Neuroscientist & Assistant Professor,
Faculty of Health Sciences & Medicine
Bond University, Queensland, Australia &
Honorary Research Fellow
The School of Biomedical Sciences,
The University of Queensland
Queensland, Australia
RESEARCHER PROFILE
Filmed in the Gold Coast, Australia | November 2025
Dr Jacob Thorstensen is an early-career Assistant Professor in Neuroscience and Physiology in the Faculty of Health Sciences & Medicine at Bond University. He is also an honorary research fellow in The School of Biomedical Sciences at The University of Queensland.
Dr Thorstensen graduated first-class honours in exercise science, completed a PhD in neurophysiology at Griffith University, and completed a post-doctoral research fellowship in neurology at The University of Queensland.
His research uses non-invasive neurostimulation techniques to study how the brain and spinal cord control muscles in human subjects.
His findings have been published in several discipline-leading scientific journals including The Journal of Physiology, Journal of Neurophysiology and Neuropharmacology and disseminated at large, international scientific meetings.
His work has unveiled several new neuroscientific mechanisms which have future applications for movement disorders. Recent recognitions include being on the Forbes 30 Under 30 list for the Healthcare & Science Category (2024) and being selected as a Career Achievement Award finalist in the 7NEWS QLD Young Achiever Awards (2025).
Dr Thorstensen sits on the editorial boards for The Journal of Physiology and Journal of Applied Physiology.
He is a part of the executive committee for the Australasian Brain Stimulation Society, and the early career researcher and education committees for the International Society of Electrophysiology and Kinesiology.
He is also part of a team that has recently been funded through a Multiple Sclerosis Australia Incubator Grant for a neurostimulation project.
Source: Supplied
https://orcid.org/0000-0002-6821-1547
-
Liver cancer biomarkers, risk prediction & progression
Dr. Rodrigo Carlessi is an expert in Cancer Genomics and Molecular Biology, with an extensive track record in liver cancer research. He leads the Cancer Genomics Group within the Liver Disease and Regeneration Laboratory at the Curtin Medical Research Institute. He has an impressive publication record, with 43 manuscripts that have collectively garnered over 2,680 citations. His research leverages cutting-edge genomics and transcriptomics technologies, as well as long-read DNA sequencing, to explore mechanisms, identify biomarkers, and develop therapeutic targets in liver disease and cancer.
-
Exercise therapy for metabolic dysfunction-associated steatotic liver disease
Dr Shelley Keating is a Senior Lecturer in Clinical Exercise Physiology and Accredited Exercise Physiologist from the School of Human Movement and Nutrition Sciences at the University of Queensland. With a strong grounding in exercise metabolism and body composition, Dr Keating’s research centres on the utility of exercise as a therapy for obesity and related cardiometabolic conditions, notably metabolic dysfunction-associated steatotic liver disease (MASLD).
-
Inner ear organoids for the study of human hearing and balance
Dr Jackie Ogier is an auditory neuroscientist, with a research focus on the molecular biology of hair cells, the specialised sensory receptors in the ear that detect sound and balance. She is a postdoctoral research fellow in the laboratory of A/Prof Bryony Nayagam, supported by a prestigious Passe and Williams foundation fellowship.
Dr Ogier’s experience broadly spans the genetics of hearing loss, disease modelling, micro dissection, primary cell culture, stem cell culture, organoids, and proteomics. Overall, she aims to generate knowledge of hearing and vestibular sensory biology.
